US Patent Issued to Regeneron Pharmaceuticals on April 8 for "Use of a VEGF antagonist to treat angiogenic eye disorders" (New York Inventor)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,268,730, issued on April 8, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Use of a VEGF antagonist to treat angiogenic eye disorders" was invented by George D. Yancopoulos (Yorktown Heights, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for treating angiogenic eye disorders by sequentially administering multiple doses of a VEGF antagonist to a patient. The methods of the present invention include the administration of multiple doses of a VEGF antagonist to a patient at a frequency of once every 8 or more weeks. The methods of the present invention are useful for the treatment of angiogeni...